Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - KIRK RANDAL J
Last Updated 
20-Mar-17
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

KIRK RANDAL J: Declared Holdings
Company/RelationshipReportedShares  Ownership
AMPLIPHI BIOSCIENCES
Beneficial Owner (10% or more)
Other OTC:APHB
(historical quotes, other insiders)
29-Dec-161,410,339  Indirect
AquaBounty Technologies, Inc.
Beneficial Owner (10% or more)
NasdaqCM:AQB
(historical quotes, profile, other insiders)
18-Jan-176,091,777  Indirect
Fibrocell Science Inc
Beneficial Owner (10% or more)
NasdaqCM:FCSC
(historical quotes, profile, other insiders)
27-Jul-1516,620,414  Indirect
Halozyme Therapeutics, Inc.
Director
NasdaqGS:HALO
(historical quotes, profile, other insiders)
4-May-16
31-May-16
3,538,253
   15,767,150
19,305,403
  Direct
  Indirect  
  Total
Oragenics, Inc.
Beneficial Owner (10% or more)
NYSE MKT:OGEN
(historical quotes, profile, other insiders)
30-Jun-1615,481,644  Indirect
Synthetic Biologics, Inc.
Beneficial Owner (10% or more)
NYSE MKT:SYN
(historical quotes, profile, other insiders)
2-Sep-1513,238,268  Indirect
TRANSGENOMIC INC COM USD0.01(PO
Beneficial Owner (10% or more)
NasdaqCM:TBIO
(historical quotes, profile, SEC, other insiders)
6-Jan-167,550,669  Indirect
Intrexon Corporation
Officer
NYSE:XON
(historical quotes, profile, other insiders)
2-Mar-1762,253,429  Indirect
ZIOPHARM Oncology Inc
Director
NasdaqCM:ZIOP
(historical quotes, profile, other insiders)
30-Dec-16
4-Jun-15
139,513
   9,569,415
9,708,928
  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
2-Mar-17 *200XON Disposition (Non Open Market) at $0 per share.
28-Feb-17 *42,810XON Acquisition (Non Open Market) at $22.26 - $23.65 per share.
(Value of about $983,000)
31-Jan-17 *41,748XON Acquisition (Non Open Market) at $21.16 - $24.77 per share.
(Value of about $959,000)
18-Jan-17 *930,530AQB Acquisition (Non Open Market)
18-Jan-17 *1,776,557AQB Disposition (Non Open Market)
18-Jan-17 *2,421,073AQB Purchase at $10.33 per share.
(Cost of $25,009,684)
30-Dec-16 *36,418XON Acquisition (Non Open Market) at $24.30 - $28.38 per share.
(Value of about $959,000)
30-Dec-16 *135,501,904AQB Statement of Ownership
30-Dec-16 17,204ZIOP Acquisition (Non Open Market) at $0 per share.
29-Dec-16 *42,000APHB Sale at $0.45 per share.
(Proceeds of $18,900)
28-Dec-16 *84,620APHB Sale at $0.47 per share.
(Proceeds of $39,771)
27-Dec-16 *50,400APHB Sale at $0.51 per share.
(Proceeds of $25,704)
13-Dec-16 *34,606XON Purchase at $28.90 per share.
(Cost of $1,000,113)
30-Nov-16 *31,348XON Acquisition (Non Open Market) at $29.18 - $32.66 per share.
(Value of about $969,000)
12-Nov-16 *428,571APHB Acquisition (Non Open Market) at $0 per share.
31-Oct-16 *37,647XON Acquisition (Non Open Market) at $26.10 - $26.68 per share.
(Value of about $994,000)
30-Sep-16 *36,291XON Acquisition (Non Open Market) at $27.44 - $28.02 per share.
(Value of about $1,006,000)
31-Aug-16 *35,509XON Acquisition (Non Open Market) at $25.24 - $29 per share.
(Value of about $963,000)
17-Aug-16 *11,828XON Option Exercise at $2.65 - $3.18 per share.
(Cost of about $34,000)
29-Jul-16 *40,481XON Acquisition (Non Open Market) at $24.55 - $25.33 per share.
(Value of about $1,010,000)
30-Jun-16 *2,261,419OGEN Purchase at $0.52 - $0.52 per share.
(Cost of about $1,176,000)
30-Jun-16 *39,498XON Acquisition (Non Open Market) at $24.61 - $25.5 per share.
(Value of about $990,000)
31-May-16 *782,184HALO Acquisition (Non Open Market)
31-May-16 *1,326,320HALO Disposition (Non Open Market)
31-May-16 *1,196,077XON Disposition (Non Open Market)
31-May-16 *744,739XON Acquisition (Non Open Market) at $24.35 - $30.74 per share.
13-May-16 *41,830XON Purchase at $23.92 - $23.92 per share.
(Cost of about $1,001,000)
4-May-16 20,202HALO Acquisition (Non Open Market) at $0 per share.
29-Apr-16 *28,556XON Acquisition (Non Open Market) at $26.73 - $37.96 per share.
31-Mar-16 *29,299XON Acquisition (Non Open Market) at $33.89 - $34.19 per share.
(Value of about $997,000)
29-Feb-16 *33,425XON Acquisition (Non Open Market) at $29.67 - $30.95 per share.
(Value of about $1,013,000)
29-Jan-16 *36,372XON Acquisition (Non Open Market) at $27.11 - $29.14 per share.
(Value of about $1,023,000)
6-Jan-16 *2,305,354TBIO Acquisition (Non Open Market) at $0 per share.
6-Jan-16 *4,474,825TBIO Purchase at $1 - $1 per share.
(Cost of about $4,475,000)
31-Dec-15 26,661ZIOP Acquisition (Non Open Market) at $0 per share.
31-Dec-15 *32,674XON Acquisition (Non Open Market) at $30.15 - $30.72 per share.
(Value of about $994,000)
11-Dec-15 *124,475XON Purchase at $29.83 - $29.86 per share.
(Cost of about $3,715,000)
7-Dec-15 *237,525XON Purchase at $30.69 - $30.69 per share.
(Cost of about $7,290,000)
1-Dec-15 *28,145XON Acquisition (Non Open Market) at $35.34 - $36.31 per share.
(Value of about $1,008,000)
1-Dec-15 *3,381,004OGEN Acquisition (Non Open Market) at $1.50 - $1.5 per share.
(Value of about $5,072,000)
1-Dec-15 *200XON Disposition (Non Open Market) at $0 per share.
2-Sep-15 *937,500SYN Purchase at $3.20 - $3.2 per share.
(Cost of about $3,000,000)
27-Jul-15 *975,987FCSC Purchase at $5.80 - $5.8 per share.
(Cost of about $5,661,000)
4-Jun-15 *8,222,953ZIOP Acquisition (Non Open Market)
4-Jun-15 *17,830,305ZIOP Disposition (Non Open Market)
6-May-15 13,175HALO Acquisition (Non Open Market) at $0 per share.
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?